Schmidtke, L.; Henke, J.; Weinmann-Menke, J. et al.
The anti-inflammatory compound Oxacyclododecindione reduces the activation of p38 MAPK in in vitro and in vivo models of chronic inflammationNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 388. 2015 S. S28-S28
Castven, D.; Fischer, M.; Heinrich, S. et al.
THE HEPATIC MICROENVIRONMENT INDUCES A CSC PHENOTYPE AND DETERMINES THE PROGNOSIS OF HCC PATIENTSJOURNAL OF HEPATOLOGY. Bd. 62. 2015 S. S244-S244
Moehler, Markus H.; Lordick, Florian; Mihaljevic, Andre L. et al.
The role of panitumumab in combination with ECX in perioperative chemotherapy of unselected patients with locally advanced gastroesophageal adenocarcinomas: Randomized phase II study of the German Cancer SocietyJOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015
Nguyen-Tat, M.; Goetz, E.; Ahrens, J. et al.
The Survival-Prognosis of Patients with Liver Cirrhosis and Hepatorenal Syndrome (HRS) is associated with the response to Terlipressin and Human AlbuminINTERNIST. Bd. 56. 2015 S. 29-29
Kampmann, E.; Diana, T.; Kanitz, M. et al.
Thyroid Stimulating but Not Blocking Autoantibodies Are Highly Prevalent in Severe and Active Thyroid-Associated Orbitopathy: A Prospective StudyINTERNATIONAL JOURNAL OF ENDOCRINOLOGY. 2015
Ponto, K. A.; Diana, T.; Binder, H. et al.
Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathyJOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. Bd. 38. H. 7. 2015 S. 769-777
Sifuentes Giraldo, Alberto; Scire, Carlo Alberto; Castaneda, Santos et al.
Timing of Onset and Cluster with Other Manifestations Influence the Spectrum of Arthritis in Anti Jo-1 Positive Antisynthetase Syndrome: Results from a Multicenter, International, Retrospective StudyARTHRITIS & RHEUMATOLOGY. Bd. 67. 2015
Itzel, Timo; Scholz, Peter; Maass, Thorsten et al.
Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesisBIOINFORMATICS. Bd. 31. H. 2. 2015 S. 216-224
Al-Batran, S. E.; Kroening, H.; Hannig, C. V. et al.
Trastuzumab in combination with different first-line chemotherapies for treatment of HER2-positive metastatic gastric or gastro-oesophageal junction cancer: Updated findings from the German non-interventional study HerMESEUROPEAN JOURNAL OF CANCER. Bd. 51. 2015 S. S444-S444
Weinmann, Arndt; Alt, Yvonne; Koch, Sandra et al.
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinomaBMC CANCER. Bd. 15. 2015